Olema Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.23-$36.25 |
Market Cap | $560.8M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.12 |
News
See moreYahoo Finance • 21 days ago
SERD Market Set for Growth During the Forecast Period (2026-2036) as AstraZeneca's ETCAMAH Approval Accelerates Adoption of Oral SERDs | DelveInsight
Yahoo Finance • last month
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
Yahoo Finance • last month
Premarket movers: AI stocks slide on warnings, Rumble, Scholar Rock jump
Yahoo Finance • last month
Olema drops after hours on AstraZeneca Etcamah data
About
CEO | Dr. Sean P. Bohen M.D., Ph.D. |
CFO | Mr. Jason O'Byrne M.B.A. |
Address | 780 Brannan Street, San Francisco, CA, United States, 94103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 150 |